Skip to main content
OpenTrials
Completed

NCT Number: NCT01520779

Recurrence of Hepatocellular Carcinoma

analysis of the risk factors of intra-hepatic distant recurrence (IDR) of hepatocellular carcinoma within 1 year after radiofrequency ablation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatocellular Carcinoma Adenocarcinoma Carcinoma Carcinoma, Hepatocellular Digestive System Diseases Digestive System Neoplasms Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Tropical medicine department

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Proved diagnosis of HCC according to AASLD practice guidelines (Bruix and Sherman, 2005).
  • Patients underwent RFA for HCC with BCLC (The Barcelona-Clinic- Liver-Cancer staging system) stage A (Bruix and Sherman, 2005) with no eligibility or ability to do transplantation or resection.
  • Patients should be followed-up for more than 12 months to exclude early recurrence i.e. recurrence within 1 year.
  • Patients with INR < 1.5 or prothrombin concentration > 50%.
  • Platelet count > 50000 cell/mm3.

Exclusion criteria

  • Presence of extra-hepatic metastasis or gross vascular invasion.
  • Child class C patients.
  • Follow up period of less than 12 months.

Treatment and study plan

Primary outcomes

  1. Recurrence of hepatocellular carcinoma

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Risk Factors for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Jan 30, 2012
Registry last updated
Oct 1, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.